Meeting
2017 Gastrointestinal Cancers Symposium
Tumor interface stability on CT imaging is an early marker of response to cytotoxic therapy in pancreatic ductal adenocarcinoma.
Authors
Christopher Wilke
The University of Texas MD Anderson Cancer Center, Houston, TX
Christopher Wilke , Ahmed Amer , Dalia Elganainy , Priya Bhosale , Ott Le , Yeonju Lee , Jordan Cloyd , Huamin Wang , Joseph M. Herman , Cullen M. Taniguchi , Andrew Rhim , Jason B. Fleming , Anirban Maitra , Robert A. Wolff , Gauri R. Varadhachary , Jeffrey Edwin Lee , Matthew H. G. Katz , Eric P. Tamm , Eugene Jon Koay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 284)
DOI
10.1200/JCO.2017.35.4_suppl.284
Abstract #
284
Poster Bd #
C20
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Discovery and validation of a quantitative, stromal-associated imaging biomarker of pancreatic ductal adenocarcinoma (PDAC).
First Author: Mohamed Zaid
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.
First Author: Qinmei Xu
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk